Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases
Adipose tissue is a critical regulator of systemic metabolism and bodily homeostasis as it secretes a myriad of adipokines, including inflammatory and anti-inflammatory cytokines. As the main storage pool of lipids, subcutaneous and visceral adipose tissues undergo marked hypertrophy and hyperplasia...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2020.602088/full |
_version_ | 1818269080848695296 |
---|---|
author | Ibrahim AlZaim Ibrahim AlZaim Safaa H. Hammoud Houssam Al-Koussa Alaa Ghazi Ali H. Eid Ali H. Eid Ali H. Eid Ahmed F. El-Yazbi Ahmed F. El-Yazbi |
author_facet | Ibrahim AlZaim Ibrahim AlZaim Safaa H. Hammoud Houssam Al-Koussa Alaa Ghazi Ali H. Eid Ali H. Eid Ali H. Eid Ahmed F. El-Yazbi Ahmed F. El-Yazbi |
author_sort | Ibrahim AlZaim |
collection | DOAJ |
description | Adipose tissue is a critical regulator of systemic metabolism and bodily homeostasis as it secretes a myriad of adipokines, including inflammatory and anti-inflammatory cytokines. As the main storage pool of lipids, subcutaneous and visceral adipose tissues undergo marked hypertrophy and hyperplasia in response to nutritional excess leading to hypoxia, adipokine dysregulation, and subsequent low-grade inflammation that is characterized by increased infiltration and activation of innate and adaptive immune cells. The specific localization, physiology, susceptibility to inflammation and the heterogeneity of the inflammatory cell population of each adipose depot are unique and thus dictate the possible complications of adipose tissue chronic inflammation. Several lines of evidence link visceral and particularly perivascular, pericardial, and perirenal adipose tissue inflammation to the development of metabolic syndrome, insulin resistance, type 2 diabetes and cardiovascular diseases. In addition to the implication of the immune system in the regulation of adipose tissue function, adipose tissue immune components are pivotal in detrimental or otherwise favorable adipose tissue remodeling and thermogenesis. Adipose tissue resident and infiltrating immune cells undergo metabolic and morphological adaptation based on the systemic energy status and thus a better comprehension of the metabolic regulation of immune cells in adipose tissues is pivotal to address complications of chronic adipose tissue inflammation. In this review, we discuss the role of adipose innate and adaptive immune cells across various physiological and pathophysiological states that pertain to the development or progression of cardiovascular diseases associated with metabolic disorders. Understanding such mechanisms allows for the exploitation of the adipose tissue-immune system crosstalk, exploring how the adipose immune system might be targeted as a strategy to treat cardiovascular derangements associated with metabolic dysfunctions. |
first_indexed | 2024-12-12T20:48:42Z |
format | Article |
id | doaj.art-3424fe24b6f94c0aadb85509c63abc5e |
institution | Directory Open Access Journal |
issn | 2297-055X |
language | English |
last_indexed | 2024-12-12T20:48:42Z |
publishDate | 2020-11-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Cardiovascular Medicine |
spelling | doaj.art-3424fe24b6f94c0aadb85509c63abc5e2022-12-22T00:12:29ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2020-11-01710.3389/fcvm.2020.602088602088Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic DiseasesIbrahim AlZaim0Ibrahim AlZaim1Safaa H. Hammoud2Houssam Al-Koussa3Alaa Ghazi4Ali H. Eid5Ali H. Eid6Ali H. Eid7Ahmed F. El-Yazbi8Ahmed F. El-Yazbi9Department of Pharmacology and Toxicology, American University of Beirut, Beirut, LebanonDepartment of Biochemistry and Molecular Genetics, American University of Beirut, Beirut, LebanonDepartment of Pharmacology and Therapeutics, Beirut Arab University, Beirut, LebanonDepartment of Pharmacology and Toxicology, American University of Beirut, Beirut, LebanonDepartment of Pharmacology and Toxicology, American University of Beirut, Beirut, LebanonDepartment of Pharmacology and Therapeutics, Faculty of Medicine, American University of Beirut, Beirut, LebanonDepartment of Basic Medical Sciences, College of Medicine, Qatar University, Doha, QatarBiomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, QatarDepartment of Pharmacology and Toxicology, American University of Beirut, Beirut, LebanonDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, EgyptAdipose tissue is a critical regulator of systemic metabolism and bodily homeostasis as it secretes a myriad of adipokines, including inflammatory and anti-inflammatory cytokines. As the main storage pool of lipids, subcutaneous and visceral adipose tissues undergo marked hypertrophy and hyperplasia in response to nutritional excess leading to hypoxia, adipokine dysregulation, and subsequent low-grade inflammation that is characterized by increased infiltration and activation of innate and adaptive immune cells. The specific localization, physiology, susceptibility to inflammation and the heterogeneity of the inflammatory cell population of each adipose depot are unique and thus dictate the possible complications of adipose tissue chronic inflammation. Several lines of evidence link visceral and particularly perivascular, pericardial, and perirenal adipose tissue inflammation to the development of metabolic syndrome, insulin resistance, type 2 diabetes and cardiovascular diseases. In addition to the implication of the immune system in the regulation of adipose tissue function, adipose tissue immune components are pivotal in detrimental or otherwise favorable adipose tissue remodeling and thermogenesis. Adipose tissue resident and infiltrating immune cells undergo metabolic and morphological adaptation based on the systemic energy status and thus a better comprehension of the metabolic regulation of immune cells in adipose tissues is pivotal to address complications of chronic adipose tissue inflammation. In this review, we discuss the role of adipose innate and adaptive immune cells across various physiological and pathophysiological states that pertain to the development or progression of cardiovascular diseases associated with metabolic disorders. Understanding such mechanisms allows for the exploitation of the adipose tissue-immune system crosstalk, exploring how the adipose immune system might be targeted as a strategy to treat cardiovascular derangements associated with metabolic dysfunctions.https://www.frontiersin.org/articles/10.3389/fcvm.2020.602088/fulladipose tissueadipose tissue inflammation-definition of metabolic syndrome-insulin resistance-myokines-systemic inflammationimmunometabolismadipose tissue immunologyadipose tissue browning |
spellingShingle | Ibrahim AlZaim Ibrahim AlZaim Safaa H. Hammoud Houssam Al-Koussa Alaa Ghazi Ali H. Eid Ali H. Eid Ali H. Eid Ahmed F. El-Yazbi Ahmed F. El-Yazbi Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases Frontiers in Cardiovascular Medicine adipose tissue adipose tissue inflammation-definition of metabolic syndrome-insulin resistance-myokines-systemic inflammation immunometabolism adipose tissue immunology adipose tissue browning |
title | Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases |
title_full | Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases |
title_fullStr | Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases |
title_full_unstemmed | Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases |
title_short | Adipose Tissue Immunomodulation: A Novel Therapeutic Approach in Cardiovascular and Metabolic Diseases |
title_sort | adipose tissue immunomodulation a novel therapeutic approach in cardiovascular and metabolic diseases |
topic | adipose tissue adipose tissue inflammation-definition of metabolic syndrome-insulin resistance-myokines-systemic inflammation immunometabolism adipose tissue immunology adipose tissue browning |
url | https://www.frontiersin.org/articles/10.3389/fcvm.2020.602088/full |
work_keys_str_mv | AT ibrahimalzaim adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases AT ibrahimalzaim adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases AT safaahhammoud adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases AT houssamalkoussa adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases AT alaaghazi adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases AT aliheid adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases AT aliheid adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases AT aliheid adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases AT ahmedfelyazbi adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases AT ahmedfelyazbi adiposetissueimmunomodulationanoveltherapeuticapproachincardiovascularandmetabolicdiseases |